Stegostoma fasciatum isolate 6-17 chromosome 24, sSteFas1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Stegostomatidae; Stegostoma.
REFSEQ INFORMATION: The reference sequence is identical to\nCM039250.1.\nAssembly name: sSteFas1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Squalomix on 2022/02/17. The\noriginal whole-genome shotgun project has the accession\nJAFIRC000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Squalomix\nAssembly Date :: 22-FEB-2021\nAssembly Method :: Platanus v. 1.2.4; P_RNA_scaffolder v.\n commit 7941e0f on May 30, at github;\n 3D-DNA v. 180922\nAssembly Name :: sSteFas1.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 95.8x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Stegostoma fasciatum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: syntaxin-binding protein 4-like
hepatic leukemia factor-like, transcript variant X1
hepatic leukemia factor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sulfotransferase family 2, cytosolic sulfotransferase 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
exocyst complex component 7, transcript variant X14
exocyst complex component 7, transcript variant X13
exocyst complex component 7, transcript variant X11
exocyst complex component 7, transcript variant X8
exocyst complex component 7, transcript variant X10
exocyst complex component 7, transcript variant X6
exocyst complex component 7, transcript variant X4
exocyst complex component 7, transcript variant X2
exocyst complex component 7, transcript variant X12
exocyst complex component 7, transcript variant X7
exocyst complex component 7, transcript variant X9
exocyst complex component 7, transcript variant X5
exocyst complex component 7, transcript variant X3
exocyst complex component 7, transcript variant X1
exocyst complex component 7, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
exocyst complex component 7, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
exocyst complex component 7, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
exocyst complex component 7, transcript variant X18
SUZ12 polycomb repressive complex 2 subunit b, transcript variant X1
SUZ12 polycomb repressive complex 2 subunit b, transcript variant X2
SUZ12 polycomb repressive complex 2 subunit b, transcript variant X3
cytokine receptor-like factor 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cytokine receptor-like factor 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
cytokine receptor-like factor 3 isoform X1
cytokine receptor-like factor 3 isoform X2
chromosome 24 C17orf75 homolog, transcript variant X1
chromosome 24 C17orf75 homolog, transcript variant X2
chromosome 24 C17orf75 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125463767, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC125463767, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC125463767 isoform X2
uncharacterized protein LOC125463767 isoform X1
mitochondrial Rho GTPase 1, transcript variant X2
mitochondrial Rho GTPase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
mitochondrial Rho GTPase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
mitochondrial Rho GTPase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
zinc finger protein 207, b, transcript variant X1
zinc finger protein 207, b, transcript variant X2
zinc finger protein 207, b, transcript variant X4
zinc finger protein 207, b, transcript variant X6
zinc finger protein 207, b, transcript variant X8
zinc finger protein 207, b, transcript variant X3
zinc finger protein 207, b, transcript variant X5
zinc finger protein 207, b, transcript variant X7
zinc finger protein 207, b, transcript variant X9
BUB3-interacting and GLEBS motif-containing protein ZNF207b isoform X1
BUB3-interacting and GLEBS motif-containing protein ZNF207b isoform X3
BUB3-interacting and GLEBS motif-containing protein ZNF207b isoform X5
BUB3-interacting and GLEBS motif-containing protein ZNF207b isoform X7
BUB3-interacting and GLEBS motif-containing protein ZNF207b isoform X2
BUB3-interacting and GLEBS motif-containing protein ZNF207b isoform X4
BUB3-interacting and GLEBS motif-containing protein ZNF207b isoform X6
BUB3-interacting and GLEBS motif-containing protein ZNF207b isoform X8
ArfGAP with dual PH domains 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ArfGAP with dual PH domains 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
arf-GAP with dual PH domain-containing protein 2 isoform X1
arf-GAP with dual PH domain-containing protein 2 isoform X2
transcription elongation factor, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ATPase family AAA domain containing 5a, transcript variant X1
ATPase family AAA domain containing 5a, transcript variant X2
ATPase family AAA domain-containing protein 5 isoform X2
ATPase family AAA domain-containing protein 5 isoform X1
diacylglycerol kinase, epsilon, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
diacylglycerol kinase, epsilon, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
diacylglycerol kinase, epsilon, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
diacylglycerol kinase, epsilon, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
diacylglycerol kinase, epsilon, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
diacylglycerol kinase, epsilon, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
diacylglycerol kinase, epsilon, transcript variant X1
diacylglycerol kinase epsilon isoform X1
diacylglycerol kinase epsilon isoform X6
diacylglycerol kinase epsilon isoform X3
diacylglycerol kinase epsilon isoform X2
diacylglycerol kinase epsilon isoform X4
diacylglycerol kinase epsilon isoform X5
retinoid-inducible serine carboxypeptidase
rab11 family-interacting protein 4-like, transcript variant X2
rab11 family-interacting protein 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
rab11 family-interacting protein 4-like isoform X1
rab11 family-interacting protein 4-like isoform X2
UTP6 small subunit processome component, transcript variant X2
UTP6 small subunit processome component, transcript variant X1
U3 small nucleolar RNA-associated protein 6 homolog isoform X1
U3 small nucleolar RNA-associated protein 6 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75% coverage of the annotated genomic feature by RNAseq alignments
phosphoribosyl pyrophosphate synthase-associated protein 1, transcript variant X2
phosphoribosyl pyrophosphate synthase-associated protein 1, transcript variant X1
phosphoribosyl pyrophosphate synthase-associated protein 1 isoform X2
phosphoribosyl pyrophosphate synthase-associated protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
(E3-independent) E2 ubiquitin-conjugating enzyme UBE2O
UTP18 small subunit processome component, transcript variant X3
UTP18 small subunit processome component, transcript variant X2
UTP18 small subunit processome component, transcript variant X1
U3 small nucleolar RNA-associated protein 18 homolog
nucleoside diphosphate kinase, transcript variant X1
nucleoside diphosphate kinase, transcript variant X2
mbt domain containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mbt domain containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mbt domain containing 1, transcript variant X1
mbt domain containing 1, transcript variant X2
mbt domain containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
mbt domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MBT domain-containing protein 1 isoform X4
MBT domain-containing protein 1 isoform X1
MBT domain-containing protein 1 isoform X6
MBT domain-containing protein 1 isoform X5
MBT domain-containing protein 1 isoform X3
MBT domain-containing protein 1 isoform X2
ankyrin repeat domain-containing protein 40
LUC7-like 3 pre-mRNA splicing factor, transcript variant X1
LUC7-like 3 pre-mRNA splicing factor, transcript variant X2
LUC7-like 3 pre-mRNA splicing factor, transcript variant X4
LUC7-like 3 pre-mRNA splicing factor, transcript variant X5
LUC7-like 3 pre-mRNA splicing factor, transcript variant X3
LUC7-like 3 pre-mRNA splicing factor, transcript variant X6
ATP-binding cassette, sub-family C (CFTR/MRP), member 3, transcript variant X3
ATP-binding cassette, sub-family C (CFTR/MRP), member 3, transcript variant X4
ATP-binding cassette, sub-family C (CFTR/MRP), member 3, transcript variant X5
ATP-binding cassette, sub-family C (CFTR/MRP), member 3, transcript variant X1
ATP-binding cassette, sub-family C (CFTR/MRP), member 3, transcript variant X2
ATP-binding cassette, sub-family C (CFTR/MRP), member 3, transcript variant X8
ATP-binding cassette sub-family C member 3 isoform X3
ATP-binding cassette sub-family C member 3 isoform X4
ATP-binding cassette sub-family C member 3 isoform X5
ATP-binding cassette sub-family C member 3 isoform X1
ATP-binding cassette sub-family C member 3 isoform X2
ATP-binding cassette sub-family C member 3 isoform X8
ATP-binding cassette, sub-family C (CFTR/MRP), member 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ATP-binding cassette sub-family C member 3 isoform X6
ATP-binding cassette, sub-family C (CFTR/MRP), member 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATP-binding cassette sub-family C member 3 isoform X7
Ras-associating and dilute domain-containing protein-like, transcript variant X1
ras-associating and dilute domain-containing protein-like isoform X1
Ras-associating and dilute domain-containing protein-like, transcript variant X3
ras-associating and dilute domain-containing protein-like isoform X3
Ras-associating and dilute domain-containing protein-like, transcript variant X2
ras-associating and dilute domain-containing protein-like isoform X2
monocyte to macrophage differentiation factor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
monocyte to macrophage differentiation factor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
monocyte to macrophage differentiation factor-like isoform X1
monocyte to macrophage differentiation factor-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and fibronectin type III domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and fibronectin type-III domain-containing protein 1
sodium-coupled monocarboxylate transporter 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
sterile alpha motif domain containing 9 like, transcript variant X3
sterile alpha motif domain containing 9 like, transcript variant X1
sterile alpha motif domain containing 9 like, transcript variant X5
sterile alpha motif domain containing 9 like, transcript variant X4
sterile alpha motif domain containing 9 like, transcript variant X6
sterile alpha motif domain containing 9 like, transcript variant X2
sterile alpha motif domain-containing protein 9-like isoform X1
sterile alpha motif domain-containing protein 9-like isoform X2
serine/threonine-protein kinase/endoribonuclease IRE1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
myeloid-associated differentiation marker homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
axin 2 (conductin, axil), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
axin 2 (conductin, axil), transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
axin 2 (conductin, axil), transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
axin 2 (conductin, axil), transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
axin 2 (conductin, axil), transcript variant X1
axin 2 (conductin, axil), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
axin 2 (conductin, axil), transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
beta-2-glycoprotein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
beta-2-glycoprotein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein kinase C alpha type, transcript variant X1
protein kinase C alpha type, transcript variant X3
protein kinase C alpha type, transcript variant X2
protein kinase C alpha type, transcript variant X4
protein kinase C alpha type, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein kinase C alpha type, transcript variant X5
voltage-dependent calcium channel gamma-5 subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
voltage-dependent calcium channel gamma-5 subunit, transcript variant X2
voltage-dependent calcium channel gamma-5 subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
voltage-dependent calcium channel gamma-5 subunit, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
voltage-dependent calcium channel gamma-5 subunit
voltage-dependent calcium channel gamma-4 subunit-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
voltage-dependent calcium channel gamma-1 subunit-like
helicase with zinc finger, transcript variant X4
helicase with zinc finger, transcript variant X2
helicase with zinc finger, transcript variant X3
helicase with zinc finger, transcript variant X6
helicase with zinc finger, transcript variant X1
helicase with zinc finger, transcript variant X5
helicase with zinc finger, transcript variant X7
probable helicase with zinc finger domain isoform X4
probable helicase with zinc finger domain isoform X2
probable helicase with zinc finger domain isoform X3
probable helicase with zinc finger domain isoform X6
probable helicase with zinc finger domain isoform X1
probable helicase with zinc finger domain isoform X5
probable helicase with zinc finger domain isoform X7
uncharacterized LOC125463511, transcript variant X2
uncharacterized LOC125463511, transcript variant X1
uncharacterized LOC125463511, transcript variant X3
26S proteasome non-ATPase regulatory subunit 12
cytoplasmic phosphatidylinositol transfer protein 1-like, transcript variant X1
cytoplasmic phosphatidylinositol transfer protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cytoplasmic phosphatidylinositol transfer protein 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cytoplasmic phosphatidylinositol transfer protein 1-like, transcript variant X2
cytoplasmic phosphatidylinositol transfer protein 1-like isoform X1
cytoplasmic phosphatidylinositol transfer protein 1-like isoform X3
cytoplasmic phosphatidylinositol transfer protein 1-like isoform X4
cytoplasmic phosphatidylinositol transfer protein 1-like, transcript variant X3
cytoplasmic phosphatidylinositol transfer protein 1-like isoform X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
bromodomain PHD finger transcription factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
nucleosome-remodeling factor subunit BPTF
UPF0450 protein C17orf58 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
UPF0450 protein C17orf58 homolog, transcript variant X1
UPF0450 protein C17orf58 homolog isoform X2
UPF0450 protein C17orf58 homolog isoform X1
transfer RNA arginine (anticodon CCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
karyopherin alpha 2 (RAG cohort 1, importin alpha 1), transcript variant X1
karyopherin alpha 2 (RAG cohort 1, importin alpha 1), transcript variant X2
SMAD specific E3 ubiquitin protein ligase 2, transcript variant X2
SMAD specific E3 ubiquitin protein ligase 2, transcript variant X1
E3 ubiquitin-protein ligase SMURF2 isoform X1
E3 ubiquitin-protein ligase SMURF2 isoform X2
trichohyalin-like, transcript variant X1
trichohyalin-like, transcript variant X2
probable ATP-dependent RNA helicase DDX5
polymerase (DNA directed), gamma 2, accessory subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
polymerase (DNA directed), gamma 2, accessory subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
DNA polymerase subunit gamma-2, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Fc receptor-like protein 5, transcript variant X2
Fc receptor-like protein 5, transcript variant X1
regulator of G protein signaling 9b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
regulator of G protein signaling 9b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
regulator of G protein signaling 9b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
regulator of G protein signaling 9b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
regulator of G-protein signaling 9b isoform X2
regulator of G-protein signaling 9b isoform X1
Rho GDP dissociation inhibitor (GDI) alpha, transcript variant X1
Rho GDP dissociation inhibitor (GDI) alpha, transcript variant X2
protein phosphatase 1 regulatory subunit 27-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
MAPK regulated corepressor interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
mapk-regulated corepressor-interacting protein 1 isoform X3
MAPK regulated corepressor interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mapk-regulated corepressor-interacting protein 1 isoform X1
MAPK regulated corepressor interacting protein 1, transcript variant X2
mapk-regulated corepressor-interacting protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
hepatocyte growth factor-regulated tyrosine kinase substrate
39S ribosomal protein L12, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
ADP-ribosylation factor-like 16, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ADP-ribosylation factor-like 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ADP-ribosylation factor-like 16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ADP-ribosylation factor-like 16, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ADP-ribosylation factor-like protein 16 isoform X1
ADP-ribosylation factor-like protein 16 isoform X2
ADP-ribosylation factor-like protein 16 isoform X3
solute carrier family 26 member 11, transcript variant X3
solute carrier family 26 member 11, transcript variant X1
solute carrier family 26 member 11, transcript variant X2
solute carrier family 26 member 11, transcript variant X4
sodium-independent sulfate anion transporter isoform X2
sodium-independent sulfate anion transporter isoform X1
sodium-independent sulfate anion transporter isoform X3
N-sulfoglucosamine sulfohydrolase (sulfamidase)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
guanine nucleotide binding protein (G protein) alpha v1, transcript variant X2
guanine nucleotide binding protein (G protein) alpha v1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
guanine nucleotide binding protein (G protein) alpha v1, transcript variant X3
guanine nucleotide binding protein (G protein) alpha v1 isoform X1
guanine nucleotide binding protein (G protein) alpha v1 isoform X2
phosphate cytidylyltransferase 2, ethanolamine, transcript variant X1
phosphate cytidylyltransferase 2, ethanolamine, transcript variant X2
phosphate cytidylyltransferase 2, ethanolamine, transcript variant X3
ethanolamine-phosphate cytidylyltransferase isoform X1
ethanolamine-phosphate cytidylyltransferase isoform X2
centromere protein X, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
centromere protein X, transcript variant X1
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X7
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X3
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X1
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X4
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X2
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X5
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X6
tether containing UBX domain for GLUT4 isoform X7
tether containing UBX domain for GLUT4 isoform X3
tether containing UBX domain for GLUT4 isoform X4
tether containing UBX domain for GLUT4 isoform X2
tether containing UBX domain for GLUT4 isoform X1
tether containing UBX domain for GLUT4 isoform X6
tether containing UBX domain for GLUT4 isoform X5
notum, palmitoleoyl-protein carboxylesterase a
palmitoleoyl-protein carboxylesterase notum1a
myeloid-associated differentiation marker-like protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
myeloid-associated differentiation marker-like protein 2 isoform X2
myeloid-associated differentiation marker-like protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
myeloid-associated differentiation marker-like protein 2 isoform X1
pyrroline-5-carboxylate reductase 1, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2-like
parvalbumin-like EF-hand-containing protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/threonine-protein kinase LMTK1-like, transcript variant X1
serine/threonine-protein kinase LMTK1-like, transcript variant X3
serine/threonine-protein kinase LMTK1-like, transcript variant X2
serine/threonine-protein kinase LMTK1-like isoform X1
serine/threonine-protein kinase LMTK1-like isoform X3
serine/threonine-protein kinase LMTK1-like isoform X2
serine/threonine-protein kinase LMTK1-like, transcript variant X6
serine/threonine-protein kinase LMTK1-like, transcript variant X4
serine/threonine-protein kinase LMTK1-like isoform X4
serine/threonine-protein kinase LMTK1-like, transcript variant X5
serine/threonine-protein kinase LMTK1-like isoform X5
brain-specific angiogenesis inhibitor 1-associated protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
regulatory associated protein of MTOR, complex 1
neuronal pentraxin 1 like, transcript variant X1
neuronal pentraxin 1 like, transcript variant X3
neuronal pentraxin 1 like, transcript variant X2
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
endonuclease V-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
endonuclease V-like, transcript variant X4
endonuclease V-like, transcript variant X1
endonuclease V-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 ubiquitin-protein ligase rnf213-alpha-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 ubiquitin-protein ligase rnf213-alpha-like, transcript variant X1
E3 ubiquitin-protein ligase rnf213-alpha-like, transcript variant X8
E3 ubiquitin-protein ligase rnf213-alpha-like, transcript variant X3
E3 ubiquitin-protein ligase rnf213-alpha-like, transcript variant X7
E3 ubiquitin-protein ligase rnf213-alpha-like, transcript variant X2
E3 ubiquitin-protein ligase rnf213-alpha-like, transcript variant X9
E3 ubiquitin-protein ligase rnf213-alpha-like, transcript variant X5
E3 ubiquitin-protein ligase rnf213-alpha-like, transcript variant X4
E3 ubiquitin-protein ligase rnf213-alpha-like isoform X1
E3 ubiquitin-protein ligase rnf213-alpha-like isoform X2
BTB/POZ domain-containing protein 17-like, transcript variant X2
BTB/POZ domain-containing protein 17-like, transcript variant X1
BTB/POZ domain-containing protein 17-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins
G protein-coupled receptor, class C, group 5, member C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
G protein-coupled receptor, class C, group 5, member C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
G-protein coupled receptor family C group 5 member C isoform X2
G-protein coupled receptor family C group 5 member C isoform X1
casein kinase 2, beta polypeptide, transcript variant X2
casein kinase 2, beta polypeptide, transcript variant X5
casein kinase 2, beta polypeptide, transcript variant X1
casein kinase 2, beta polypeptide, transcript variant X4
casein kinase 2, beta polypeptide, transcript variant X3
coiled-coil domain-containing protein 137
oxidoreductase-like domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
oxidoreductase-like domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein oxld1 isoform X1
oxidoreductase-like domain-containing protein 1 isoform X2
baculoviral IAP repeat-containing protein 5a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
threonine aldolase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
threonine aldolase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
threonine aldolase 1, transcript variant X3
threonine aldolase 1, transcript variant X4
threonine aldolase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial, transcript variant X2
CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial, transcript variant X3
CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial isoform X1
CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial isoform X2
CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin carboxyl-terminal hydrolase 36
soluble calcium-activated nucleotidase 1-like, transcript variant X2
soluble calcium-activated nucleotidase 1-like, transcript variant X1
soluble calcium-activated nucleotidase 1-like isoform X1
soluble calcium-activated nucleotidase 1-like isoform X2
component of oligomeric golgi complex 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
component of oligomeric golgi complex 1, transcript variant X2
conserved oligomeric Golgi complex subunit 1 isoform X1
conserved oligomeric Golgi complex subunit 1 isoform X2
component of oligomeric golgi complex 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
conserved oligomeric Golgi complex subunit 1 isoform X3
dual specificity mitogen-activated protein kinase kinase 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
dual specificity mitogen-activated protein kinase kinase 6 isoform X1
dual specificity mitogen-activated protein kinase kinase 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dual specificity mitogen-activated protein kinase kinase 6 isoform X2
inward rectifier potassium channel 16-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
inward rectifier potassium channel 16-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
inward rectifier potassium channel 16-like, transcript variant X12
inward rectifier potassium channel 16-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inward rectifier potassium channel 16-like, transcript variant X10
inward rectifier potassium channel 16-like, transcript variant X3
inward rectifier potassium channel 16-like, transcript variant X4
inward rectifier potassium channel 16-like, transcript variant X5
inward rectifier potassium channel 16-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
inward rectifier potassium channel 16-like, transcript variant X2
inward rectifier potassium channel 16-like, transcript variant X9
inward rectifier potassium channel 16-like, transcript variant X8
inward rectifier potassium channel 16-like
inward rectifier potassium channel 2, transcript variant X1
inward rectifier potassium channel 2, transcript variant X4
inward rectifier potassium channel 2, transcript variant X3
inward rectifier potassium channel 2, transcript variant X2
inward rectifier potassium channel 2, transcript variant X5
COORDINATES: nucleotide motif:Rfam:12.0:RF00563
uncharacterized LOC125463810, transcript variant X2
uncharacterized LOC125463810, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 180 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC125463842, transcript variant X1
uncharacterized LOC125463842, transcript variant X2
zinc transporter ZIP11-like, transcript variant X2
zinc transporter ZIP11-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 129 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
E3 ubiquitin-protein ligase rnf213-alpha-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
transmembrane channel-like protein 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane channel-like protein 7, transcript variant X1
transmembrane channel-like protein 7 isoform X2
transmembrane channel-like protein 7 isoform X1
transmembrane channel-like protein 7, transcript variant X3
transmembrane channel-like protein 7 isoform X3
transmembrane channel-like protein 6, transcript variant X1
transmembrane channel-like protein 6, transcript variant X4
transmembrane channel-like protein 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane channel-like protein 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
zinc finger CCCH domain-containing protein 11A-like, transcript variant X1
zinc finger CCCH domain-containing protein 11A-like, transcript variant X2
uncharacterized protein LOC125463697 isoform X1
zinc finger CCCH domain-containing protein 11A-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
fatty acid-binding protein 1, liver-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transcription factor MafG, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
transcription factor MafG, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transcription factor MafG, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transcription factor MafG, transcript variant X6
transcription factor MafG, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transcription factor MafG, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
NAD-dependent protein deacetylase sirtuin-7 isoform X3
NAD-dependent protein deacetylase sirtuin-7 isoform X1
NAD-dependent protein deacetylase sirtuin-7 isoform X2
carcinoembryonic antigen-related cell adhesion molecule 1-like, transcript variant X1
carcinoembryonic antigen-related cell adhesion molecule 1-like, transcript variant X4
carcinoembryonic antigen-related cell adhesion molecule 1-like, transcript variant X5
carcinoembryonic antigen-related cell adhesion molecule 1-like, transcript variant X3
carcinoembryonic antigen-related cell adhesion molecule 1-like, transcript variant X6
carcinoembryonic antigen-related cell adhesion molecule 1-like, transcript variant X7
carcinoembryonic antigen-related cell adhesion molecule 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
carcinoembryonic antigen-related cell adhesion molecule 5-like isoform X4
carcinoembryonic antigen-related cell adhesion molecule 1-like isoform X6
phosphodiesterase 6G, cGMP-specific, rod, gamma, paralog b
WD repeat domain, phosphoinositide interacting 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WD repeat domain, phosphoinositide interacting 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
WD repeat domain, phosphoinositide interacting 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
WD repeat domain, phosphoinositide interacting 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
WD repeat domain, phosphoinositide interacting 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
WD repeat domain, phosphoinositide interacting 1, transcript variant X6
WD repeat domain, phosphoinositide interacting 1, transcript variant X4
WD repeat domain phosphoinositide-interacting protein 1 isoform X1
WD repeat domain phosphoinositide-interacting protein 1 isoform X2
WD repeat domain phosphoinositide-interacting protein 1 isoform X3
WD repeat domain phosphoinositide-interacting protein 1 isoform X6
WD repeat domain phosphoinositide-interacting protein 1 isoform X4
WD repeat domain phosphoinositide-interacting protein 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
monocarboxylate transporter 7-like, transcript variant X1
monocarboxylate transporter 7-like isoform X1
monocarboxylate transporter 7-like, transcript variant X6
monocarboxylate transporter 7-like, transcript variant X3
monocarboxylate transporter 7-like, transcript variant X4
monocarboxylate transporter 7-like, transcript variant X5
monocarboxylate transporter 7-like, transcript variant X2
monocarboxylate transporter 7-like, transcript variant X7
monocarboxylate transporter 7-like isoform X2
monocarboxylate transporter 7-like isoform X4
monocarboxylate transporter 7-like isoform X3
monocarboxylate transporter 7-like isoform X5
archaemetzincin-2, transcript variant X3
archaemetzincin-2, transcript variant X4
archaemetzincin-2, transcript variant X1
archaemetzincin-2, transcript variant X2
guanine nucleotide binding protein (G protein), alpha 13a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
guanine nucleotide-binding protein subunit alpha-13a
APC11 anaphase promoting complex subunit 11 homolog (yeast)
caspase recruitment domain family, member 14, transcript variant X2
caspase recruitment domain family, member 14, transcript variant X3
caspase recruitment domain family, member 14, transcript variant X1
caspase recruitment domain-containing protein 14
lysosomal alpha-glucosidase-like, transcript variant X1
lysosomal alpha-glucosidase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
coiled-coil domain containing 40, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
coiled-coil domain containing 40, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
coiled-coil domain-containing protein 40 isoform X1
coiled-coil domain-containing protein 40 isoform X2
TBC1 domain family, member 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TBC1 domain family, member 16, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TBC1 domain family, member 16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TBC1 domain family, member 16, transcript variant X4
chromobox homolog 2 (Drosophila Pc class)
cAMP-dependent protein kinase type I-alpha regulatory subunit, transcript variant X3
cAMP-dependent protein kinase type I-alpha regulatory subunit, transcript variant X1
cAMP-dependent protein kinase type I-alpha regulatory subunit, transcript variant X2
cAMP-dependent protein kinase type I-alpha regulatory subunit
platelet-derived growth factor subunit A-like, transcript variant X1
platelet-derived growth factor subunit A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
platelet-derived growth factor subunit A-like isoform X1
platelet-derived growth factor subunit A-like isoform X2
FAM20A golgi associated secretory pathway pseudokinase, transcript variant X2
FAM20A golgi associated secretory pathway pseudokinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
NPL4 homolog, ubiquitin recognition factor, transcript variant X2
NPL4 homolog, ubiquitin recognition factor, transcript variant X1
NPL4 homolog, ubiquitin recognition factor, transcript variant X3
nuclear protein localization protein 4 homolog isoform X1
nuclear protein localization protein 4 homolog isoform X2
nuclear protein localization protein 4 homolog isoform X3
FA core complex associated protein 100, transcript variant X3
FA core complex associated protein 100, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
FA core complex associated protein 100, transcript variant X1
Fanconi anemia core complex-associated protein 100 isoform X3
Fanconi anemia core complex-associated protein 100 isoform X2
Fanconi anemia core complex-associated protein 100 isoform X1
fascin actin-bundling protein 2b, retinal
BAH domain and coiled-coil containing 1b, transcript variant X3
BAH domain and coiled-coil containing 1b, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BAH domain and coiled-coil containing 1b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
BAH domain and coiled-coil containing 1b, transcript variant X1
BAH domain and coiled-coil containing 1b, transcript variant X2
BAH domain and coiled-coil containing 1b, transcript variant X4
BAH and coiled-coil domain-containing protein 1 isoform X3
BAH and coiled-coil domain-containing protein 1 isoform X2
BAH and coiled-coil domain-containing protein 1 isoform X1
uncharacterized LOC125463521, transcript variant X1
uncharacterized LOC125463521, transcript variant X2
solute carrier family 38 member 10, transcript variant X1
solute carrier family 38 member 10, transcript variant X2
putative sodium-coupled neutral amino acid transporter 10 isoform X1
putative sodium-coupled neutral amino acid transporter 10 isoform X2
NADH:ubiquinone oxidoreductase complex assembly factor 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 8
TEPSIN adaptor related protein complex 4 accessory protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized protein LOC100150256 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized protein LOC100150256 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized si:dkey-21c1.4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized si:dkey-21c1.4, transcript variant X1
uncharacterized si:dkey-21c1.4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized si:dkey-21c1.4, transcript variant X2
uncharacterized si:dkey-21c1.4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized si:dkey-21c1.4, transcript variant X8
uncharacterized si:dkey-21c1.4, transcript variant X7
uncharacterized si:dkey-21c1.4, transcript variant X3
uncharacterized protein si:dkey-21c1.4 isoform X1
uncharacterized protein si:dkey-21c1.4 isoform X2
cleavage and polyadenylation specificity factor subunit 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins
sidekick cell adhesion molecule 2b, transcript variant X1
sidekick cell adhesion molecule 2b, transcript variant X2
CDC42 effector protein (Rho GTPase binding) 4b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
CDC42 effector protein (Rho GTPase binding) 4b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
dynein, axonemal, intermediate chain 2b, transcript variant X3
dynein, axonemal, intermediate chain 2b, transcript variant X4
dynein, axonemal, intermediate chain 2b, transcript variant X5
dynein, axonemal, intermediate chain 2b, transcript variant X1
dynein, axonemal, intermediate chain 2b, transcript variant X6
dynein, axonemal, intermediate chain 2b, transcript variant X7
dynein, axonemal, intermediate chain 2b, transcript variant X2
dynein axonemal intermediate chain 2 isoform X2
dynein axonemal intermediate chain 2 isoform X1
dynein axonemal intermediate chain 2 isoform X3
kinesin family member 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
kinesin family member 19, transcript variant X2
ATP-binding cassette, sub-family A (ABC1), member 5, transcript variant X1
ATP-binding cassette, sub-family A (ABC1), member 5, transcript variant X2
ATP-binding cassette sub-family A member 5 isoform X1
ATP-binding cassette sub-family A member 5 isoform X2
uncharacterized LOC125463776, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC125463776, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized protein LOC125463776 isoform X1
uncharacterized protein LOC125463776 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat-containing protein 45
ras-related C3 botulinum toxin substrate 3, transcript variant X2
ras-related C3 botulinum toxin substrate 3 isoform X2
ras-related C3 botulinum toxin substrate 3, transcript variant X1
ras-related C3 botulinum toxin substrate 3 isoform X1
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase, transcript variant X1
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase, transcript variant X2
beta-1,3-N-acetylglucosaminyltransferase radical fringe isoform X2
beta-1,3-N-acetylglucosaminyltransferase radical fringe isoform X1
beta-1,3-N-acetylglucosaminyltransferase radical fringe isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC125463593, transcript variant X2
uncharacterized LOC125463593, transcript variant X1
dihydrouridine synthase 1-like (S. cerevisiae), transcript variant X1
dihydrouridine synthase 1-like (S. cerevisiae), transcript variant X2
dihydrouridine synthase 1-like (S. cerevisiae), transcript variant X3
tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like
fatty acid synthase, transcript variant X1
fatty acid synthase, transcript variant X2
coiled-coil domain containing 57, transcript variant X2
coiled-coil domain containing 57, transcript variant X5
coiled-coil domain containing 57, transcript variant X3
coiled-coil domain containing 57, transcript variant X4
coiled-coil domain containing 57, transcript variant X1
coiled-coil domain-containing protein 57 isoform X4
coiled-coil domain-containing protein 57 isoform X2
coiled-coil domain-containing protein 57 isoform X3
coiled-coil domain-containing protein 57 isoform X1
monocarboxylate transporter 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
monocarboxylate transporter 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
monocarboxylate transporter 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
monocarboxylate transporter 4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 76 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
complement C1q tumor necrosis factor-related protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
cytosolic endo-beta-N-acetylglucosaminidase
RNA binding protein fox-1 homolog 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
ectonucleotide pyrophosphatase/phosphodiesterase family member 7-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ectonucleotide pyrophosphatase/phosphodiesterase family member 7-like, transcript variant X2
ectonucleotide pyrophosphatase/phosphodiesterase family member 7-like isoform X1
ectonucleotide pyrophosphatase/phosphodiesterase family member 7-like isoform X2
matrix-remodeling-associated protein 7-like, transcript variant X3
matrix-remodeling-associated protein 7-like, transcript variant X2
matrix-remodeling-associated protein 7-like, transcript variant X1
matrix-remodeling-associated protein 7-like, transcript variant X4
matrix-remodeling-associated protein 7-like isoform X3
matrix-remodeling-associated protein 7-like isoform X2
matrix-remodeling-associated protein 7-like isoform X1
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
bifunctional arginine demethylase and lysyl-hydroxylase JMJD6
histone-arginine methyltransferase METTL23-like, transcript variant X3
histone-arginine methyltransferase METTL23-like, transcript variant X2
histone-arginine methyltransferase METTL23-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
histone-arginine methyltransferase METTL23-like isoform X1
histone-arginine methyltransferase METTL23-like isoform X2
histone-arginine methyltransferase METTL23-like isoform X3
serine/arginine-rich splicing factor 2-like, transcript variant X1
serine/arginine-rich splicing factor 2-like, transcript variant X2
serine/arginine-rich splicing factor 2-like
major facilitator superfamily domain containing 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
major facilitator superfamily domain containing 11, transcript variant X1
major facilitator superfamily domain containing 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B, transcript variant X2
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B, transcript variant X1
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B isoform X3
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B isoform X2
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B isoform X1
trinucleotide repeat containing adaptor 6C1, transcript variant X4
trinucleotide repeat containing adaptor 6C1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
trinucleotide repeat containing adaptor 6C1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
trinucleotide repeat containing adaptor 6C1, transcript variant X3
trinucleotide repeat containing adaptor 6C1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
trinucleotide repeat containing adaptor 6C1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
trinucleotide repeat containing adaptor 6C1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
trinucleotide repeat containing adaptor 6C1, transcript variant X2
trinucleotide repeat containing adaptor 6C1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
trinucleotide repeat containing adaptor 6C1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
trinucleotide repeat containing adaptor 6C1, transcript variant X9
trinucleotide repeat containing adaptor 6C1, transcript variant X10
trinucleotide repeat-containing gene 6C protein isoform X4
trinucleotide repeat-containing gene 6C protein isoform X6
trinucleotide repeat-containing gene 6C protein isoform X12
trinucleotide repeat-containing gene 6C protein isoform X3
trinucleotide repeat-containing gene 6C protein isoform X11
trinucleotide repeat-containing gene 6C protein isoform X1
trinucleotide repeat-containing gene 6C protein isoform X7
trinucleotide repeat-containing gene 6C protein isoform X2
trinucleotide repeat-containing gene 6C protein isoform X8
trinucleotide repeat-containing gene 6C protein isoform X5
trinucleotide repeat-containing gene 6C protein isoform X9
trinucleotide repeat-containing gene 6C protein isoform X10
neuronal-specific septin-3-like isoform X2
neuronal-specific septin-3-like isoform X5
neuronal-specific septin-3-like isoform X1
neuronal-specific septin-3-like isoform X6
neuronal-specific septin-3-like isoform X4
neuronal-specific septin-3-like isoform X3
programmed cell death 1 ligand 1-like, transcript variant X3
programmed cell death 1 ligand 1-like, transcript variant X2
programmed cell death 1 ligand 1-like, transcript variant X5
programmed cell death 1 ligand 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
programmed cell death 1 ligand 1-like, transcript variant X4
programmed cell death 1 ligand 1-like isoform X3
programmed cell death 1 ligand 1-like isoform X2
programmed cell death 1 ligand 1-like isoform X1
programmed cell death 1 ligand 1-like isoform X5
programmed cell death 1 ligand 1-like isoform X4
uncharacterized LOC125463660, transcript variant X7
uncharacterized LOC125463660, transcript variant X9
uncharacterized LOC125463660, transcript variant X3
uncharacterized LOC125463660, transcript variant X8
uncharacterized LOC125463660, transcript variant X2
uncharacterized LOC125463660, transcript variant X6
uncharacterized LOC125463660, transcript variant X1
uncharacterized protein LOC125463660 isoform X5
uncharacterized protein LOC125463660 isoform X4
uncharacterized protein LOC125463660 isoform X1
uncharacterized protein LOC125463660 isoform X6
uncharacterized LOC125463660, transcript variant X10
uncharacterized LOC125463660, transcript variant X4
uncharacterized LOC125463660, transcript variant X5
uncharacterized protein LOC125463660 isoform X2
uncharacterized protein LOC125463660 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
urotensin-2 receptor 2, transcript variant X2
urotensin-2 receptor 2, transcript variant X1
urotensin-2 receptor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
hexosaminidase D-like, transcript variant X1
hexosaminidase D-like, transcript variant X3
hexosaminidase D-like, transcript variant X2
hexosaminidase D-like, transcript variant X4
cytochrome b-245 chaperone 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
cytochrome b-245 chaperone 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cytochrome b-245 chaperone 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nuclear prelamin A recognition factor, transcript variant X3
nuclear prelamin A recognition factor, transcript variant X2
nuclear prelamin A recognition factor, transcript variant X4
nuclear prelamin A recognition factor, transcript variant X1
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cilia and flagella associated protein 52, transcript variant X3
cilia and flagella associated protein 52, transcript variant X4
cilia and flagella associated protein 52, transcript variant X2
cilia and flagella associated protein 52, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cilia- and flagella-associated protein 52 isoform X2
cilia- and flagella-associated protein 52 isoform X1
cilia- and flagella-associated protein 52 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 43a
phosphoinositide-3-kinase, regulatory subunit 5, transcript variant X1
phosphoinositide-3-kinase, regulatory subunit 5, transcript variant X2
phosphoinositide 3-kinase regulatory subunit 5 isoform X1
phosphoinositide 3-kinase regulatory subunit 5 isoform X2
phosphoinositide 3-kinase regulatory subunit 6-like, transcript variant X1
phosphoinositide 3-kinase regulatory subunit 6-like, transcript variant X2
phosphoinositide 3-kinase regulatory subunit 6-like
radical S-adenosyl methionine domain containing 1, transcript variant X1
radical S-adenosyl methionine domain-containing protein 1, mitochondrial isoform X1
radical S-adenosyl methionine domain containing 1, transcript variant X3
radical S-adenosyl methionine domain containing 1, transcript variant X2
radical S-adenosyl methionine domain containing 1, transcript variant X4
radical S-adenosyl methionine domain-containing protein 1, mitochondrial isoform X2
radical S-adenosyl methionine domain-containing protein 1, mitochondrial isoform X3
acyl-CoA synthetase family member 2, transcript variant X1
acyl-CoA synthetase family member 2, transcript variant X2
medium-chain acyl-CoA ligase ACSF2, mitochondrial isoform X1
medium-chain acyl-CoA ligase ACSF2, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
leucine rich repeat containing 59, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
leucine rich repeat containing 59, transcript variant X1
leucine-rich repeat-containing protein 59
essential meiotic structure-specific endonuclease 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
essential meiotic structure-specific endonuclease 1, transcript variant X2
essential meiotic structure-specific endonuclease 1, transcript variant X3
39S ribosomal protein L27, mitochondrial
protein HEATR9-like, transcript variant X2
protein HEATR9-like, transcript variant X1
protein HEATR9-like, transcript variant X3
glutamate receptor ionotropic, NMDA 2C-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamate receptor ionotropic, NMDA 2C-like, transcript variant X2
glutamate receptor ionotropic, NMDA 2C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate receptor ionotropic, NMDA 2C-like
probable ATP-dependent RNA helicase DDX41, transcript variant X3
probable ATP-dependent RNA helicase DDX41, transcript variant X4
probable ATP-dependent RNA helicase DDX41, transcript variant X1
probable ATP-dependent RNA helicase DDX41, transcript variant X2
probable ATP-dependent RNA helicase DDX41
uncharacterized LOC125463782, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF01268
uncharacterized LOC125463782, transcript variant X1
transmembrane protein 260, transcript variant X2
transmembrane protein 260, transcript variant X1
LLGL scribble cell polarity complex component 2, transcript variant X2
LLGL scribble cell polarity complex component 2, transcript variant X1
LLGL scribble cell polarity complex component 2, transcript variant X3
LLGL scribble cell polarity complex component 2, transcript variant X4
LLGL scribble cell polarity complex component 2
tripartite motif-containing protein 16-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
jupiter microtubule associated homolog 2-like, transcript variant X2
jupiter microtubule associated homolog 2-like, transcript variant X1
jupiter microtubule associated homolog 1-like isoform X2
jupiter microtubule associated homolog 1-like isoform X1
jupiter microtubule associated homolog 2-like, transcript variant X3
jupiter microtubule associated homolog 2-like isoform X3
nuclear pore complex protein Nup85 isoform X1
nuclear pore complex protein Nup85 isoform X2
nuclear pore complex protein Nup85 isoform X3
nuclear pore complex protein Nup85 isoform X4
nuclear pore complex protein Nup85 isoform X5
golgi associated, gamma adaptin ear containing, ARF binding protein 3b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
golgi associated, gamma adaptin ear containing, ARF binding protein 3b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ADP-ribosylation factor-binding protein GGA3 isoform X1
ADP-ribosylation factor-binding protein GGA3 isoform X2
Na(+)/H(+) exchange regulatory cofactor NHE-RF1-like, transcript variant X2
Na(+)/H(+) exchange regulatory cofactor NHE-RF1-like, transcript variant X1
Na(+)/H(+) exchange regulatory cofactor NHE-RF1-like isoform X1
Na(+)/H(+) exchange regulatory cofactor NHE-RF1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
major facilitator superfamily domain containing 6-like, transcript variant X2
major facilitator superfamily domain containing 6-like, transcript variant X1
major facilitator superfamily domain containing 6-like, transcript variant X3
major facilitator superfamily domain-containing protein 6-like
uncharacterized protein LOC100151763 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC100151763 homolog, transcript variant X2
uncharacterized protein LOC100151763 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
bMERB domain-containing protein 1 isoform X1
uncharacterized protein LOC100151763 homolog, transcript variant X4
uncharacterized protein LOC100151763 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC100151763 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
bMERB domain-containing protein 1 isoform X2
bMERB domain-containing protein 1 isoform X3
nuclear distribution protein nudE-like 1, transcript variant X4
nuclear distribution protein nudE-like 1, transcript variant X6
nuclear distribution protein nudE-like 1, transcript variant X1
nuclear distribution protein nudE-like 1, transcript variant X5
nuclear distribution protein nudE-like 1, transcript variant X2
nuclear distribution protein nudE-like 1, transcript variant X3
nuclear distribution protein nudE-like 1 isoform X2
nuclear distribution protein nudE-like 1 isoform X1
nuclear distribution protein nudE-like 1 isoform X3
RING finger protein 222, transcript variant X5
RING finger protein 222, transcript variant X1
RING finger protein 222, transcript variant X3
RING finger protein 222, transcript variant X2
RING finger protein 222, transcript variant X4
testis-expressed protein 47, transcript variant X2
testis-expressed protein 47, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
testis-expressed protein 47, transcript variant X4
testis-expressed protein 47, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
testis-expressed protein 47, transcript variant X1
rho GTPase-activating protein 44-like, transcript variant X4
rho GTPase-activating protein 44-like, transcript variant X7
rho GTPase-activating protein 44-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rho GTPase-activating protein 44-like, transcript variant X6
rho GTPase-activating protein 44-like, transcript variant X1
rho GTPase-activating protein 44-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
rho GTPase-activating protein 44-like, transcript variant X8
rho GTPase-activating protein 44-like, transcript variant X10
rho GTPase-activating protein 44-like, transcript variant X9
rho GTPase-activating protein 44-like, transcript variant X11
rho GTPase-activating protein 44-like, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
rho GTPase-activating protein 44-like, transcript variant X12
rho GTPase-activating protein 44-like isoform X4
rho GTPase-activating protein 44-like isoform X13
rho GTPase-activating protein 44-like isoform X10
rho GTPase-activating protein 44-like isoform X3
rho GTPase-activating protein 44-like isoform X12
rho GTPase-activating protein 44-like isoform X9
rho GTPase-activating protein 44-like isoform X2
rho GTPase-activating protein 44-like isoform X11
rho GTPase-activating protein 44-like isoform X8
rho GTPase-activating protein 44-like isoform X6
rho GTPase-activating protein 44-like isoform X1
rho GTPase-activating protein 44-like isoform X7
rho GTPase-activating protein 44-like, transcript variant X5
rho GTPase-activating protein 44-like isoform X5
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
F-box and WD repeat domain containing 10, transcript variant X1
F-box and WD repeat domain containing 10, transcript variant X2
F-box and WD repeat domain containing protein 10B isoform X1
F-box and WD repeat domain containing protein 10B isoform X2
trans-golgi network vesicle protein 23 homolog B (S. cerevisiae), transcript variant X1
trans-golgi network vesicle protein 23 homolog B (S. cerevisiae), transcript variant X2
Golgi apparatus membrane protein TVP23 homolog B isoform X1
Golgi apparatus membrane protein TVP23 homolog B isoform X2
uncharacterized LOC125463769, transcript variant X2
uncharacterized LOC125463769, transcript variant X1
heparan sulfate glucosamine 3-O-sulfotransferase 3B1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
protoheme IX farnesyltransferase, mitochondrial
heparan sulfate glucosamine 3-O-sulfotransferase 3A1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
acyl-coenzyme A diphosphatase NUDT19-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: acyl-coenzyme A diphosphatase NUDT19-like
polyadenylate-binding protein 1A-like, transcript variant X2
polyadenylate-binding protein 1A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
polyadenylate-binding protein 1A-like isoform X1
polyadenylate-binding protein 1A-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
tripartite motif-containing protein 16-like protein, transcript variant X2
tripartite motif-containing protein 16-like protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tripartite motif-containing protein 16-like protein isoform X1
tripartite motif-containing protein 16-like protein isoform X2
meteorin like, glial cell differentiation regulator a
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
WD repeat domain 45B, transcript variant X1
WD repeat domain 45B, transcript variant X3
WD repeat domain 45B, transcript variant X2
WD repeat domain phosphoinositide-interacting protein 3 isoform X1
WD repeat domain phosphoinositide-interacting protein 3 isoform X3
WD repeat domain phosphoinositide-interacting protein 3 isoform X2
forkhead box protein K2-like, transcript variant X2
forkhead box protein K2-like, transcript variant X3
forkhead box protein K2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
phosphoinositide-interacting protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
phosphoinositide-interacting protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
phosphoinositide-interacting protein-like
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
protein shisa-6-like, transcript variant X1
protein shisa-6-like, transcript variant X2
protein shisa-6-like, transcript variant X3
protein shisa-6-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
elaC ribonuclease Z 2, transcript variant X1
elaC ribonuclease Z 2, transcript variant X2
zinc phosphodiesterase ELAC protein 2 isoform X1
zinc phosphodiesterase ELAC protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dual specificity mitogen-activated protein kinase kinase 4-like, transcript variant X4
dual specificity mitogen-activated protein kinase kinase 4-like, transcript variant X1
dual specificity mitogen-activated protein kinase kinase 4-like, transcript variant X2
dual specificity mitogen-activated protein kinase kinase 4-like, transcript variant X3
dual specificity mitogen-activated protein kinase kinase 4-like isoform X1
dual specificity mitogen-activated protein kinase kinase 4-like isoform X2
dual specificity mitogen-activated protein kinase kinase 4-like isoform X3
dual specificity mitogen-activated protein kinase kinase 4-like isoform X4
ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent
manganese-dependent ADP-ribose/CDP-alcohol diphosphatase
protein SCO1 homolog, mitochondrial-like, transcript variant X1
protein SCO1 homolog, mitochondrial-like, transcript variant X2
protein SCO1 homolog, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 493 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 385 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 397 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 402 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 397 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 401 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 666 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
growth arrest-specific 7b, transcript variant X1
growth arrest-specific protein 7 isoform X1
growth arrest-specific 7b, transcript variant X2
growth arrest-specific protein 7 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
heparan sulfate (glucosamine) 3-O-sulfotransferase 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
dehydrogenase/reductase (SDR family) member 7Cb, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
dehydrogenase/reductase (SDR family) member 7Cb, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dehydrogenase/reductase (SDR family) member 7Cb, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dehydrogenase/reductase (SDR family) member 7Cb
splicing factor U2AF 65 kDa subunit-like, transcript variant X1
splicing factor U2AF 65 kDa subunit-like, transcript variant X2
splicing factor U2AF 65 kDa subunit-like, transcript variant X3
splicing factor U2AF 65 kDa subunit-like isoform X1
splicing factor U2AF 65 kDa subunit-like isoform X2
splicing factor U2AF 65 kDa subunit-like isoform X3
splicing factor U2AF 65 kDa subunit-like, transcript variant X4
splicing factor U2AF 65 kDa subunit-like isoform X4
protein phosphatase 1 regulatory subunit 7-like, transcript variant X1
protein phosphatase 1 regulatory subunit 7-like, transcript variant X2
protein phosphatase 1 regulatory subunit 7-like isoform X1
protein phosphatase 1 regulatory subunit 7-like isoform X2
protein phosphatase 1 regulatory subunit 7-like, transcript variant X3
myosin phosphatase Rho interacting protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
myosin phosphatase Rho interacting protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125463565, transcript variant X2
uncharacterized LOC125463565, transcript variant X1
uncharacterized LOC125463565, transcript variant X4
uncharacterized LOC125463565, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
NADPH:adrenodoxin oxidoreductase, mitochondrial
calcium channel, voltage-dependent, T type, alpha 1G subunit
voltage-dependent T-type calcium channel subunit alpha-1G
uncharacterized LOC125463545, transcript variant X1
uncharacterized LOC125463545, transcript variant X2
spermatogenesis associated 20, transcript variant X2
spermatogenesis associated 20, transcript variant X1
spermatogenesis associated 20, transcript variant X4
spermatogenesis associated 20, transcript variant X5
spermatogenesis associated 20, transcript variant X3
spermatogenesis associated 20, transcript variant X6
spermatogenesis-associated protein 20 isoform X2
spermatogenesis-associated protein 20 isoform X1
spermatogenesis-associated protein 20 isoform X3
TSEN54 tRNA splicing endonuclease subunit, transcript variant X1
TSEN54 tRNA splicing endonuclease subunit, transcript variant X2
TSEN54 tRNA splicing endonuclease subunit, transcript variant X4
tRNA-splicing endonuclease subunit Sen54 isoform X1
tRNA-splicing endonuclease subunit Sen54 isoform X2
tRNA-splicing endonuclease subunit Sen54 isoform X4
TSEN54 tRNA splicing endonuclease subunit, transcript variant X3
tRNA-splicing endonuclease subunit Sen54 isoform X3
melanin-concentrating hormone receptor 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
melanin-concentrating hormone receptor 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
melanin-concentrating hormone receptor 1-like isoform X1
melanin-concentrating hormone receptor 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transmembrane protein 94, transcript variant X3
transmembrane protein 94, transcript variant X2
transmembrane protein 94, transcript variant X1
transmembrane protein 94, transcript variant X4
transient receptor potential cation channel subfamily V member 6-like
transient receptor potential cation channel subfamily V member 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transient receptor potential cation channel subfamily V member 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transient receptor potential cation channel subfamily V member 6-like isoform X2
transient receptor potential cation channel subfamily V member 6-like isoform X1
serine/threonine-protein kinase SBK1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine/threonine-protein kinase SBK1-like, transcript variant X1
serine/threonine-protein kinase SBK1-like
E3 ubiquitin/ISG15 ligase TRIM25-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
E3 ubiquitin/ISG15 ligase TRIM25-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
E3 ubiquitin/ISG15 ligase TRIM25-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
E3 ubiquitin/ISG15 ligase TRIM25-like isoform X3
E3 ubiquitin/ISG15 ligase TRIM25-like isoform X2
E3 ubiquitin/ISG15 ligase TRIM25-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitochondrial ribosomal protein L38, transcript variant X3
mitochondrial ribosomal protein L38, transcript variant X2
mitochondrial ribosomal protein L38, transcript variant X1
39S ribosomal protein L38, mitochondrial isoform X1
39S ribosomal protein L38, mitochondrial isoform X2
fas-binding factor 1 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
fas-binding factor 1 homolog, transcript variant X1
fas-binding factor 1 homolog, transcript variant X2
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
acyl-CoA oxidase 1, palmitoyl, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
acyl-CoA oxidase 1, palmitoyl, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
acyl-CoA oxidase 1, palmitoyl, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
peroxisomal acyl-coenzyme A oxidase 1 isoform X1
peroxisomal acyl-coenzyme A oxidase 1 isoform X2
peroxisomal acyl-coenzyme A oxidase 1 isoform X3
signal recognition particle subunit SRP68
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
N-acetyltransferase 9 (GCN5-related, putative), transcript variant X1
N-acetyltransferase 9 (GCN5-related, putative), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
baculoviral IAP repeat-containing protein 7-like, transcript variant X1
baculoviral IAP repeat-containing protein 7-like, transcript variant X2
baculoviral IAP repeat-containing protein 7-like isoform X1
baculoviral IAP repeat-containing protein 7-like isoform X2
telomere attrition and p53 response 1 protein-like
Usher syndrome type-1G protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
Usher syndrome type-1G protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Usher syndrome type-1G protein-like isoform X2
Usher syndrome type-1G protein-like isoform X1
ATP synthase peripheral stalk subunit d, transcript variant X1
ATP synthase peripheral stalk subunit d, transcript variant X2
BTB/POZ domain-containing protein KCTD2-like
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
peptidyl-tRNA hydrolase ICT1, mitochondrial
cerebellar degeneration-related protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
WW domain-binding protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
WW domain-binding protein 2-like, transcript variant X3
WW domain-binding protein 2-like isoform X1
WW domain-binding protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
WW domain-binding protein 2-like isoform X2
WW domain-binding protein 2-like, transcript variant X4
WW domain-binding protein 2-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized si:ch211-250n8.1, transcript variant X3
uncharacterized si:ch211-250n8.1, transcript variant X1
uncharacterized si:ch211-250n8.1, transcript variant X4
uncharacterized protein si:ch211-250n8.1 isoform X3
uncharacterized protein si:ch211-250n8.1 isoform X1
uncharacterized protein si:ch211-250n8.1 isoform X4
uncharacterized si:ch211-250n8.1, transcript variant X2
uncharacterized protein si:ch211-250n8.1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC125463732, transcript variant X2
uncharacterized LOC125463732, transcript variant X1
uncharacterized LOC125463732, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial thiamine pyrophosphate carrier
ras-related protein Rab-37-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ras-related protein Rab-37-like, transcript variant X3
ras-related protein Rab-37-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ras-related protein Rab-37-like isoform X1
ras-related protein Rab-37-like isoform X3
ras-related protein Rab-37-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
xylosyltransferase II, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
xylosyltransferase II, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
zinc finger protein 239-like, transcript variant X3
zinc finger protein 239-like, transcript variant X4
zinc finger protein 239-like, transcript variant X5
zinc finger protein 239-like, transcript variant X2
zinc finger protein 239-like, transcript variant X1
zinc finger protein 250-like, transcript variant X3
zinc finger protein 250-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
zinc finger protein 250-like, transcript variant X2
zinc finger protein 271-like, transcript variant X1
zinc finger protein 271-like, transcript variant X4
zinc finger protein 271-like, transcript variant X2
zinc finger protein 271-like, transcript variant X5
zinc finger protein 271-like, transcript variant X3
zinc finger protein 271-like, transcript variant X6
uncharacterized protein LOC125463472 isoform X3
uncharacterized protein LOC125463472 isoform X2